NexImmune, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
NexImmune, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q2 2024.
  • NexImmune, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $0.000, a 100% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $0 -$703K -100% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $0 -$836K -100% Mar 31, 2024 10-Q 2024-05-20
Q4 2023 $46.7K -$920K -95.2% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $536K -$559K -51.1% Sep 30, 2023 10-Q 2023-11-17
Q2 2023 $703K -$518K -42.4% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $836K -$509K -37.9% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $967K +$967K Dec 31, 2022 10-K 2024-04-16
Q3 2022 $1.1M Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.22M Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $1.35M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.